Schedule 13G ownership disclosure
Perspective Therapeutics Inc
Common Stock, $0.001 par value · CUSIP: 46489V302
Event date: 2026-02-20
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Avidity Partners Management LP
Shares: 6,049,999.00 · Class: 5.3%
- Avidity Partners Management (GP) LLC
Shares: 6,049,999.00 · Class: 5.3%
- Avidity Capital Partners Fund (GP) LP
Shares: 6,049,999.00 · Class: 5.3%
- Avidity Capital Partners (GP) LLC
Shares: 6,049,999.00 · Class: 5.3%
- Avidity Private Master Fund I LP
Shares: 5,849,999.00 · Class: 5.1%
- Michael Gregory
Shares: 6,049,999.00 · Class: 5.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-26-001548
- Form type
- SCHEDULE 13G
- Filer
- Avidity Partners Management LP
- CIK
- CIK 1791827
- Filed
- Mar 10, 2026
- Reporting period
- Feb 20, 2026
- Description
- Schedule 13G beneficial ownership